{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:35:53Z","timestamp":1758126953882},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T00:00:00Z","timestamp":1204761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s10038-008-0268-0","type":"journal-article","created":{"date-parts":[[2008,3,5]],"date-time":"2008-03-05T08:52:34Z","timestamp":1204707154000},"page":"447-453","source":"Crossref","is-referenced-by-count":13,"title":["Introduction of a CD40L genomic fragment via a human artificial chromosome vector permits cell-type-specific gene expression and induces immunoglobulin secretion"],"prefix":"10.1038","volume":"53","author":[{"given":"Hidetoshi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanze C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Oshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,6]]},"reference":[{"key":"268_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF (1995) T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270:475\u2013480","journal-title":"Science"},{"key":"268_CR2","doi-asserted-by":"publisher","first-page":"13964","DOI":"10.1074\/jbc.M601553200","volume":"281","author":"C Bossen","year":"2006","unstructured":"Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, Ambrose C, Tschopp J, Schneider P (2006) Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem 281:13964\u201313971","journal-title":"J Biol Chem"},{"key":"268_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/3233","volume":"4","author":"MP Brown","year":"1998","unstructured":"Brown MP, Topham DJ, Sangster MY, Zhao J, Flynn KJ, Surman SL, Woodland DL, Doherty PC, Farr AG, Pattengale PK, Brenner MK (1998) Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 4:1253\u20131260","journal-title":"Nat Med"},{"key":"268_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.288.5466.669","volume":"288","author":"M Cavazzana-Calvo","year":"2000","unstructured":"Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669\u2013672","journal-title":"Science"},{"key":"268_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1385\/IR:27:2-3:185","volume":"27","author":"RQ Cron","year":"2002","unstructured":"Cron RQ (2002) CD154 transcription regulation in primary human CD4 T cells. Immunol Res 27:185\u2013202","journal-title":"Immunol Res"},{"key":"268_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/361541a0","volume":"361","author":"JP DiSanto","year":"1993","unstructured":"DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361:541\u2013543","journal-title":"Nature"},{"key":"268_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00335-003-4002-0","volume":"14","author":"AM Doherty","year":"2003","unstructured":"Doherty AM, Fisher EM (2003) Microcell-mediated chromosome transfer (MMCT): small cells with huge potential. Mamm Genome 14:583\u2013592","journal-title":"Mamm Genome"},{"key":"268_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/sj.gt.3302150","volume":"10","author":"HB Gaspar","year":"2003","unstructured":"Gaspar HB, Howe S, Thrasher AJ (2003) Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency. Gene Ther 10:1999\u20132004","journal-title":"Gene Ther"},{"key":"268_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","volume":"16","author":"IS Grewal","year":"1998","unstructured":"Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111\u2013135","journal-title":"Annu Rev Immunol"},{"key":"268_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.gt.3301763","volume":"9","author":"BR Grimes","year":"2002","unstructured":"Grimes BR, Warburton PE, Farr CJ (2002) Chromosome engineering: prospects for gene therapy. Gene Ther 9:713\u2013718","journal-title":"Gene Ther"},{"key":"268_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa012616","volume":"346","author":"S Hacein-Bey-Abina","year":"2002","unstructured":"Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185\u20131193","journal-title":"N Engl J Med"},{"key":"268_CR12","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.gt.3302483","volume":"12","author":"M Kakeda","year":"2005","unstructured":"Kakeda M, Hiratsuka M, Nagata K, Kuroiwa Y, Kakitani M, Katoh M, Oshimura M, Tomizuka K (2005) Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts. Gene Ther 12:852\u2013856","journal-title":"Gene Ther"},{"key":"268_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2004.06.145","volume":"321","author":"M Katoh","year":"2004","unstructured":"Katoh M, Ayabe F, Norikane S, Okada T, Masumoto H, Horike S, Shirayoshi Y, Oshimura M (2004) Construction of a novel human artificial chromosome vector for gene delivery. Biochem Biophys Res Commun 321:280\u2013290","journal-title":"Biochem Biophys Res Commun"},{"key":"268_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/361539a0","volume":"361","author":"U Korthauer","year":"1993","unstructured":"Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539\u2013541","journal-title":"Nature"},{"key":"268_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-065X.1994.tb00846.x","volume":"138","author":"RA Kroczek","year":"1994","unstructured":"Kroczek RA, Graf D, Brugnoni D, Giliani S, Korthuer U, Ugazio A, Senger G, Mages HW, Villa A, Notarangelo LD (1994) Defective expression of CD40 ligand on T cells causes \u201cX-linked immunodeficiency with hyper-IgM (HIGM1)\u201d. Immunol Rev 138:39\u201359","journal-title":"Immunol Rev"},{"key":"268_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/sj.gt.3301754","volume":"9","author":"Y Kuroiwa","year":"2002","unstructured":"Kuroiwa Y, Yoshida H, Ohshima T, Shinohara T, Ohguma A, Kazuki Y, Oshimura M, Ishida I, Tomizuka K (2002) The use of chromosome-based vectors for animal transgenesis. Gene Ther 9:708\u2013712","journal-title":"Gene Ther"},{"key":"268_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0168-9525(02)02679-3","volume":"18","author":"Z Larin","year":"2002","unstructured":"Larin Z, Mejia JE (2002) Advances in human artificial chromosome technology. Trends Genet 18:313\u2013319","journal-title":"Trends Genet"},{"key":"268_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/geno.2000.6451","volume":"73","author":"EC Lee","year":"2001","unstructured":"Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56\u201365","journal-title":"Genomics"},{"key":"268_CR19","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1182\/blood-2002-09-2800","volume":"101","author":"LM Muul","year":"2003","unstructured":"Muul LM, Tuschong LM, Soenen SL, Jagadeesh GJ, Ramsey WJ, Long Z, Carter CS, Garabedian EK, Alleyne M, Brown M, Bernstein W, Schurman SH, Fleisher TA, Leitman SF, Dunbar CE, Blaese RM, Candotti F (2003) Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial. Blood 101:2563\u20132569","journal-title":"Blood"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V91.1.30","volume":"91","author":"M Onodera","year":"1998","unstructured":"Onodera M, Ariga T, Kawamura N, Kobayashi I, Ohtsu M, Yamada M, Tame A, Furuta H, Okano M, Matsumoto S, Kotani H, McGarrity GJ, Blaese RM, Sakiyama Y (1998) Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood 91:30\u201336","journal-title":"Blood"},{"key":"268_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1634\/stemcells.2005-0021","volume":"23","author":"X Ren","year":"2005","unstructured":"Ren X, Katoh M, Hoshiya H, Kurimasa A, Inoue T, Ayabe F, Shibata K, Toguchida J, Oshimura M (2005) A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells. Stem Cells 23:1608\u20131616","journal-title":"Stem Cells"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","volume":"151","author":"M Roy","year":"1993","unstructured":"Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ (1993) The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 151:2497\u20132510","journal-title":"J Immunol"},{"key":"268_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jgm.236","volume":"4","author":"R Saffery","year":"2002","unstructured":"Saffery R, Choo KH (2002) Strategies for engineering human chromosomes with therapeutic potential. J Gene Med 4:5\u201313","journal-title":"J Gene Med"},{"key":"268_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4049\/jimmunol.156.1.8","volume":"156","author":"RD Stout","year":"1996","unstructured":"Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA (1996) Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 156:8\u201311","journal-title":"J Immunol"},{"key":"268_CR25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4049\/jimmunol.170.2.727","volume":"170","author":"AD Straw","year":"2003","unstructured":"Straw AD, MacDonald AS, Denkers EY, Pearce EJ (2003) CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J Immunol 170:727\u2013734","journal-title":"J Immunol"},{"key":"268_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10038-005-0334-9","volume":"51","author":"H Yamada","year":"2006","unstructured":"Yamada H, Kunisato A, Kawahara M, Tahimic CG, Ren X, Ueda H, Nagamune T, Katoh M, Inoue T, Nishikawa M, Oshimura M (2006) Exogenous gene expression and growth regulation of hematopoietic cells via a novel human artificial chromosome. J Hum Genet 51:147\u2013150","journal-title":"J Hum Genet"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg200857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg200857","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg200857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T20:52:23Z","timestamp":1684270343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg200857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,6]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s10038-008-0268-0","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,6]]}}}